Defects of TGF-beta receptor signaling in mammary cell tumorigenesis.

M. G. Brattain, Y. Ko, S. S. Banerji, G. Wu, J. K. Willson

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Transforming growth factor beta (TGF-beta) receptor expression and signal transduction in human breast cancer are reviewed as a function of estrogen receptor (ER) expression. ER+ breast cancer cells are generally resistant to the inhibitory effects of TGF-beta. The only known exception appears to be MCF-7 early passage cells which are initially sensitive to TGF-beta, but gain resistance after long-term passage in tissue culture. A number of studies have shown that loss of sensitivity is due to inadequate TGF-beta type II (TGFRII) receptor expression. Stable transfection of TGFRII into ER+ breast cancer cell lines results in the acquisition of TGF-beta sensitivity and reversion of malignancy. Although there are exceptions, ER- breast cancer cells usually express TGFRII, but nevertheless show a low level of sensitivity to TGF-beta. Thus resistance in these cells implies a postreceptor mechanism. Given the frequency with which loss of TGF-beta sensitivity has been associated with loss of TGFRII, the ER- breast cancer cell lines may represent valuable models for identifying postreceptor mechanisms of resistance.

Original languageEnglish (US)
Pages (from-to)365-372
Number of pages8
JournalJournal of mammary gland biology and neoplasia
Volume1
Issue number4
DOIs
StatePublished - Oct 1996

Fingerprint

Transforming Growth Factor beta Receptors
Transforming Growth Factor beta
Estrogen Receptors
Carcinogenesis
Breast
Breast Neoplasms
Cell Line
Transfection
Signal Transduction
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Defects of TGF-beta receptor signaling in mammary cell tumorigenesis. / Brattain, M. G.; Ko, Y.; Banerji, S. S.; Wu, G.; Willson, J. K.

In: Journal of mammary gland biology and neoplasia, Vol. 1, No. 4, 10.1996, p. 365-372.

Research output: Contribution to journalReview article

Brattain, M. G. ; Ko, Y. ; Banerji, S. S. ; Wu, G. ; Willson, J. K. / Defects of TGF-beta receptor signaling in mammary cell tumorigenesis. In: Journal of mammary gland biology and neoplasia. 1996 ; Vol. 1, No. 4. pp. 365-372.
@article{825ad540aa544404960ba755fcd8c1e4,
title = "Defects of TGF-beta receptor signaling in mammary cell tumorigenesis.",
abstract = "Transforming growth factor beta (TGF-beta) receptor expression and signal transduction in human breast cancer are reviewed as a function of estrogen receptor (ER) expression. ER+ breast cancer cells are generally resistant to the inhibitory effects of TGF-beta. The only known exception appears to be MCF-7 early passage cells which are initially sensitive to TGF-beta, but gain resistance after long-term passage in tissue culture. A number of studies have shown that loss of sensitivity is due to inadequate TGF-beta type II (TGFRII) receptor expression. Stable transfection of TGFRII into ER+ breast cancer cell lines results in the acquisition of TGF-beta sensitivity and reversion of malignancy. Although there are exceptions, ER- breast cancer cells usually express TGFRII, but nevertheless show a low level of sensitivity to TGF-beta. Thus resistance in these cells implies a postreceptor mechanism. Given the frequency with which loss of TGF-beta sensitivity has been associated with loss of TGFRII, the ER- breast cancer cell lines may represent valuable models for identifying postreceptor mechanisms of resistance.",
author = "Brattain, {M. G.} and Y. Ko and Banerji, {S. S.} and G. Wu and Willson, {J. K.}",
year = "1996",
month = "10",
doi = "10.1007/BF02017392",
language = "English (US)",
volume = "1",
pages = "365--372",
journal = "Journal of Mammary Gland Biology and Neoplasia",
issn = "1083-3021",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Defects of TGF-beta receptor signaling in mammary cell tumorigenesis.

AU - Brattain, M. G.

AU - Ko, Y.

AU - Banerji, S. S.

AU - Wu, G.

AU - Willson, J. K.

PY - 1996/10

Y1 - 1996/10

N2 - Transforming growth factor beta (TGF-beta) receptor expression and signal transduction in human breast cancer are reviewed as a function of estrogen receptor (ER) expression. ER+ breast cancer cells are generally resistant to the inhibitory effects of TGF-beta. The only known exception appears to be MCF-7 early passage cells which are initially sensitive to TGF-beta, but gain resistance after long-term passage in tissue culture. A number of studies have shown that loss of sensitivity is due to inadequate TGF-beta type II (TGFRII) receptor expression. Stable transfection of TGFRII into ER+ breast cancer cell lines results in the acquisition of TGF-beta sensitivity and reversion of malignancy. Although there are exceptions, ER- breast cancer cells usually express TGFRII, but nevertheless show a low level of sensitivity to TGF-beta. Thus resistance in these cells implies a postreceptor mechanism. Given the frequency with which loss of TGF-beta sensitivity has been associated with loss of TGFRII, the ER- breast cancer cell lines may represent valuable models for identifying postreceptor mechanisms of resistance.

AB - Transforming growth factor beta (TGF-beta) receptor expression and signal transduction in human breast cancer are reviewed as a function of estrogen receptor (ER) expression. ER+ breast cancer cells are generally resistant to the inhibitory effects of TGF-beta. The only known exception appears to be MCF-7 early passage cells which are initially sensitive to TGF-beta, but gain resistance after long-term passage in tissue culture. A number of studies have shown that loss of sensitivity is due to inadequate TGF-beta type II (TGFRII) receptor expression. Stable transfection of TGFRII into ER+ breast cancer cell lines results in the acquisition of TGF-beta sensitivity and reversion of malignancy. Although there are exceptions, ER- breast cancer cells usually express TGFRII, but nevertheless show a low level of sensitivity to TGF-beta. Thus resistance in these cells implies a postreceptor mechanism. Given the frequency with which loss of TGF-beta sensitivity has been associated with loss of TGFRII, the ER- breast cancer cell lines may represent valuable models for identifying postreceptor mechanisms of resistance.

UR - http://www.scopus.com/inward/record.url?scp=0030251468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030251468&partnerID=8YFLogxK

U2 - 10.1007/BF02017392

DO - 10.1007/BF02017392

M3 - Review article

C2 - 10887510

AN - SCOPUS:0030251468

VL - 1

SP - 365

EP - 372

JO - Journal of Mammary Gland Biology and Neoplasia

JF - Journal of Mammary Gland Biology and Neoplasia

SN - 1083-3021

IS - 4

ER -